{"id":345226,"date":"2025-08-24T17:28:52","date_gmt":"2025-08-24T17:28:52","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-cytokinetics-incorporated\/"},"modified":"2025-08-24T17:28:52","modified_gmt":"2025-08-24T17:28:52","slug":"how-to-buy-cytokinetics-incorporated","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/","title":{"rendered":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-345226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Cytokinetics (CYTK) hisseleri nas\u0131l al\u0131n\u0131r ve bu biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Cytokinetics (CYTK) hisseleri nas\u0131l al\u0131n\u0131r ve bu biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Kalp hastal\u0131\u011f\u0131 tedavisinde devrim yaratabilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Cytokinetics (CYTK), deneysel kalp ilac\u0131 aficamten ile t\u0131bbi bir at\u0131l\u0131m\u0131n e\u015fi\u011finde duruyor. Bu biyoteknoloji firmas\u0131 ya h\u0131zla y\u00fckselecek ya da t\u00f6kezleyecek\u2014bu da onu 2025'in en heyecan verici yat\u0131r\u0131m hikayelerinden biri yap\u0131yor. Bu y\u00fcksek riskli, y\u00fcksek \u00f6d\u00fcll\u00fc oyunun portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kalp hastal\u0131\u011f\u0131 tedavisinde devrim yaratabilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Cytokinetics (CYTK), deneysel kalp ilac\u0131 aficamten ile t\u0131bbi bir at\u0131l\u0131m\u0131n e\u015fi\u011finde duruyor. Bu biyoteknoloji firmas\u0131 ya h\u0131zla y\u00fckselecek ya da t\u00f6kezleyecek\u2014bu da onu 2025'in en heyecan verici yat\u0131r\u0131m hikayelerinden biri yap\u0131yor. Bu y\u00fcksek riskli, y\u00fcksek \u00f6d\u00fcll\u00fc oyunun portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 CYTK Hisse Senedi: G\u00fcncel Fiyat, Trendler ve Kritik Tarihler<\/h2> <p>24 A\u011fustos 2025 itibar\u0131yla Cytokinetics (CYTK), NASDAQ'da <strong>38,34 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize i\u015faretleyin: <strong>26 Aral\u0131k 2025<\/strong> kesinlikle kritik\u2014FDA'n\u0131n aficamten onay\u0131yla ilgili karar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Tarihsel olarak, bu t\u00fcr d\u00fczenleyici kararlar biyoteknoloji hisselerinde b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7ar.<\/p> <h3>FDA Kararlar\u0131 CYTK Gibi Biyoteknoloji Hisselerini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>2 May\u0131s 2025<\/td><td>FDA Gecikme Duyurusu<\/td><td>42,90 $<\/td><td>-%12,9 (1 g\u00fcn)<\/td><\/tr> <tr><td>15 \u015eubat 2025<\/td><td>Olumlu Deneme Verisi<\/td><td>35,20 $<\/td><td>+%18,4 (3 g\u00fcn)<\/td><\/tr> <tr><td>8 Kas\u0131m 2024<\/td><td>Ortakl\u0131k Haberi<\/td><td>32,80 $<\/td><td>+%9,1 (1 hafta)<\/td><\/tr> <tr><td>12 A\u011fustos 2024<\/td><td>\u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>38,50 $<\/td><td>-%6,2 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>10 May\u0131s 2024<\/td><td>Klinik G\u00fcncelleme<\/td><td>41,20 $<\/td><td>+%4,8 (olumlu)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: FDA ile ilgili haberler en b\u00fcy\u00fck dalgalanmalara neden olur\u2014olumlu kararlar bir gecede %50-100 kazan\u00e7 tetikleyebilirken, gecikmeler veya reddedilmeler hissenin de\u011ferinin yar\u0131s\u0131n\u0131 silebilir. May\u0131s 2025 gecikmesi an\u0131nda panik sat\u0131\u015f\u0131na yol a\u00e7t\u0131, ancak hisse o zamandan beri diren\u00e7 g\u00f6sterdi.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3> <p>CYTK hisseleri bir h\u0131z treni gibi hareket etti, y\u0131lba\u015f\u0131ndan bu yana <strong>%19,56<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131 ancak son zamanlarda istikrar g\u00f6steriyor:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 47,66 $ (tahmini YTD ba\u015flang\u0131\u00e7 noktas\u0131)<\/li> <li><strong>Nisan 2025<\/strong>: 42,90 $ (FDA gecikme endi\u015fesi \u00f6ncesi)<\/li> <li><strong>May\u0131s 2025<\/strong>: 37,35 $ (gecikme sonras\u0131 \u00e7\u00f6k\u00fc\u015f)<\/li> <li><strong>Haziran 2025<\/strong>: 36,18 $ (konsolidasyon d\u00f6nemi)<\/li> <li><strong>Temmuz 2025<\/strong>: 37,32-38,54 $ aral\u0131\u011f\u0131 (toparlanma denemesi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 38,34 $ (mevcut istikrar)<\/li> <\/ul> <p><strong>Neden bu volatilite?<\/strong> Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlara ba\u011fl\u0131 olarak y\u00fckselir ve d\u00fc\u015fer. CYTK'nin t\u00fcm gelece\u011fi aficamten'in Aral\u0131k FDA karar\u0131na ba\u011fl\u0131d\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli (2025)<\/h3> <p><strong>Aral\u0131k 2025 Hedefi<\/strong>: FDA aficamten'i onaylarsa 75-85 $ (+%95-120 y\u00fckseli\u015f)<br> <strong>En K\u00f6t\u00fc Senaryo<\/strong>: Reddedilirse 20-25 $ (-%35-48 d\u00fc\u015f\u00fc\u015f)<\/p> <p>Aral\u0131k karar\u0131n\u0131n ikili do\u011fas\u0131 a\u015f\u0131r\u0131 senaryolar yarat\u0131yor. \u00c7o\u011fu analist <strong>AL<\/strong> notu veriyor ve 27 analist takip ediyor: 4 tut, 17 al, 6 g\u00fc\u00e7l\u00fc al olarak <a href=\"https:\/\/valueinvesting.io\/CYTK\/estimates\">Value Investing verilerine<\/a> g\u00f6re.<\/p> <h3>Orta Vadeli (2026)<\/h3> <p><strong>Onay Senaryosu<\/strong>: 100-120 $ (ticari lansman ba\u015far\u0131s\u0131)<br> <strong>Reddetme Senaryosu<\/strong>: 15-20 $ (yeniden yap\u0131land\u0131rma veya sat\u0131n alma hedefi)<\/p> <h3>Uzun Vadeli (2028-2030)<\/h3> <p><strong>Bo\u011fa Senaryosu<\/strong>: 150-200+ $ (ba\u015far\u0131l\u0131 ila\u00e7 lansmanlar\u0131, \u00fcr\u00fcn hatt\u0131 geni\u015flemesi)<br> <strong>Temel Senaryo<\/strong>: 80-120 $ (istikrarl\u0131 ticari performans)<br> <strong>Ay\u0131 Senaryosu<\/strong>: &lt;10 $ (klinik ba\u015far\u0131s\u0131zl\u0131klar, finansal s\u0131k\u0131nt\u0131)<\/p> <p><strong>Karar<\/strong>: Y\u00dcKSEK R\u0130SK ama potansiyel Y\u00dcKSEK \u00d6D\u00dcL \u2192 <strong>R\u0130SK TOLERANSI OLAN YATIRIMCILAR \u0130\u00c7\u0130N SPEK\u00dcLAT\u0130F ALIM<\/strong><\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>\ud83d\udea8 Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>FDA Reddetme Riski<\/strong>: Aral\u0131k karar\u0131 \u015firketi tamamen raydan \u00e7\u0131karabilir<\/li> <li><strong>SEC Soru\u015fturmas\u0131<\/strong>: Klinik veri i\u015fleme uygulamalar\u0131na y\u00f6nelik devam eden inceleme (<a href=\"https:\/\/www.ainvest.com\/news\/cytokinetics-scrutiny-sec-investigation-investor-implications-2505\/\">AInvest raporu<\/a>)<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: 1,1 milyar $ rezerv olmas\u0131na ra\u011fmen ila\u00e7 geli\u015ftirme h\u0131zla nakit t\u00fcketiyor<\/li> <li><strong>Rekabet<\/strong>: Benzer kalp tedavileri geli\u015ftiren di\u011fer \u015firketler<\/li> <li><strong>\u0130kili Olay Riski<\/strong>: Tek ilaca ba\u011f\u0131ml\u0131l\u0131k hisseyi a\u015f\u0131r\u0131 volatil yap\u0131yor<\/li> <\/ul> <h3>\ud83d\udc9a 2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>1,1 Milyar Dolar Nakit Rezerv<\/strong>: Ticarile\u015ftirme i\u00e7in b\u00fcy\u00fck nakit rezervi (<a href=\"https:\/\/ir.cytokinetics.com\/press-releases\/press-release-details\/2025\/Cytokinetics-Announces-New-PDUFA-Date-for-Aficamten-in-Obstructive-Hypertrophic-Cardiomyopathy-05-01-2025\/default.aspx\">\u015eirket raporu<\/a>)<\/li> <li><strong>Potansiyel Blockbuster<\/strong>: Aficamten zirve sat\u0131\u015flarda 1,5-2 milyar $ gelir yaratabilir<\/li> <li><strong>G\u00fc\u00e7l\u00fc Faz 3 Verileri<\/strong>: Etkinli\u011fi destekleyen sa\u011flam klinik sonu\u00e7lar<\/li> <li><strong>K\u00fcresel Ortakl\u0131klar<\/strong>: Asya pazarlar\u0131 i\u00e7in Ji Xing Pharmaceuticals ile anla\u015fmalar<\/li> <li><strong>Sekt\u00f6r Trendi<\/strong>: Kardiyovask\u00fcler ila\u00e7lar b\u00fcy\u00fck kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 temsil ediyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>A\u00e7\u0131kl\u0131k Bekleyin<\/strong>: Aral\u0131k FDA karar\u0131 y\u00f6n verecek\u2014o zamana kadar b\u00fcy\u00fck pozisyonlardan ka\u00e7\u0131n\u0131n<\/li> <li><strong>K\u00fc\u00e7\u00fck Pozisyon Boyutlar\u0131<\/strong>: Al\u0131m yap\u0131yorsan\u0131z, CYTK'y\u0131 toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden az tutun<\/li> <li><strong>Zarar Durdur Seviyeleri Belirleyin<\/strong>: FDA aficamten'i reddederse felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 koruma sa\u011flay\u0131n<\/li> <li><strong>SEC Soru\u015fturmas\u0131n\u0131 Takip Edin<\/strong>: \u00c7\u00f6z\u00fcm \u00f6nemli bir y\u00fck\u00fc kald\u0131rabilir<\/li> <\/ol> <p><strong>Mizahi Bak\u0131\u015f<\/strong>: \"CYTK ticareti, anestezisiz kalp ameliyat\u0131 yapmak gibidir\u2014ba\u015far\u0131l\u0131 olursan\u0131z heyecan verici, olmazsa ac\u0131 verici. Belki defibrilat\u00f6r\u00fc yan\u0131n\u0131zda tutun!\"<\/p> <h2>\u2705 Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Y\u00fcksek risk nedeniyle k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"CYTK\" aramas\u0131 yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014bir\u00e7ok platform $0 komisyon sunar<\/td><\/tr> <tr><td>6<\/td><td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td><td>FDA haberleri ve \u00f6nemli fiyat hareketlerini takip edin<\/td><\/tr> <tr><td>7<\/td><td>Dolar maliyeti ortalamas\u0131 yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td><td>Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 zamana yay<\/td><\/tr> <tr><td>8<\/td><td>Tezinizi belgeleyin<\/td><td>Duygusal kararlardan ka\u00e7\u0131nmak i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option CYTK Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>CYTK'nin potansiyeline ilgi duyan ancak risklerden \u00e7ekinenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri minimal riskle test edin<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> \u2014 Herhangi bir kimlik belgesini y\u00fckleyin ve h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdan veya banka kartlar\u0131yla karlar\u0131n\u0131za eri\u015fim esnekli\u011fi<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, CYTK gibi y\u00fcksek volatiliteye sahip hisselerde \u00f6nemli sermaye riske atmadan denemeler yapmak i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Cytokinetics: Kalp \u0130lac\u0131 Yenilik\u00e7isi<\/h2> <p>Cytokinetics, 28 y\u0131ll\u0131k tarihinde kritik bir d\u00f6n\u00fcm noktas\u0131nda. 1997'de kurulan ve merkezi G\u00fcney San Francisco'da bulunan \u015firket, kalp tedavilerine odaklanan kas biyolojisi ara\u015ft\u0131rmalar\u0131nda \u00f6nc\u00fc oldu. 498 \u00e7al\u0131\u015fan\u0131 ve 4,59 milyar $ piyasa de\u011feri ile CYTK, klasik bir biyoteknoloji hikayesini temsil ediyor: y\u0131llarca s\u00fcren ara\u015ft\u0131rmalar, kritik bir d\u00fczenleyici karar\u0131n e\u015fi\u011finde.<\/p> <p>\u015eirketin \u00f6nc\u00fc ilac\u0131 aficamten, kalp kas\u0131 fonksiyonunu etkileyen obstr\u00fcktif hipertrofik kardiyomiyopatiyi hedefliyor. Onaylan\u0131rsa, Cytokinetics'in ilk ticari \u00fcr\u00fcn\u00fc olacak ve \u015firketi ara\u015ft\u0131rma odakl\u0131dan gelir getiren bir yap\u0131ya d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Cytokinetics CEO'su Robert Blum, 2013'ten beri \u015firketi bir\u00e7ok klinik deneme a\u015famas\u0131ndan ge\u00e7iriyor ve hala ilk FDA onay\u0131n\u0131 bekleyen en uzun s\u00fcre g\u00f6rev yapan biyoteknoloji CEO'lar\u0131ndan biri\u2014bu hem sabr\u0131n hem de ila\u00e7 geli\u015ftirme zorluklar\u0131n\u0131n bir g\u00f6stergesi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 CYTK Hisse Senedi: G\u00fcncel Fiyat, Trendler ve Kritik Tarihler<\/h2>\n<p>24 A\u011fustos 2025 itibar\u0131yla Cytokinetics (CYTK), NASDAQ&#8217;da <strong>38,34 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize i\u015faretleyin: <strong>26 Aral\u0131k 2025<\/strong> kesinlikle kritik\u2014FDA&#8217;n\u0131n aficamten onay\u0131yla ilgili karar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Tarihsel olarak, bu t\u00fcr d\u00fczenleyici kararlar biyoteknoloji hisselerinde b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7ar.<\/p>\n<h3>FDA Kararlar\u0131 CYTK Gibi Biyoteknoloji Hisselerini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2 May\u0131s 2025<\/td>\n<td>FDA Gecikme Duyurusu<\/td>\n<td>42,90 $<\/td>\n<td>-%12,9 (1 g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>15 \u015eubat 2025<\/td>\n<td>Olumlu Deneme Verisi<\/td>\n<td>35,20 $<\/td>\n<td>+%18,4 (3 g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>8 Kas\u0131m 2024<\/td>\n<td>Ortakl\u0131k Haberi<\/td>\n<td>32,80 $<\/td>\n<td>+%9,1 (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>12 A\u011fustos 2024<\/td>\n<td>\u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>38,50 $<\/td>\n<td>-%6,2 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>10 May\u0131s 2024<\/td>\n<td>Klinik G\u00fcncelleme<\/td>\n<td>41,20 $<\/td>\n<td>+%4,8 (olumlu)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: FDA ile ilgili haberler en b\u00fcy\u00fck dalgalanmalara neden olur\u2014olumlu kararlar bir gecede %50-100 kazan\u00e7 tetikleyebilirken, gecikmeler veya reddedilmeler hissenin de\u011ferinin yar\u0131s\u0131n\u0131 silebilir. May\u0131s 2025 gecikmesi an\u0131nda panik sat\u0131\u015f\u0131na yol a\u00e7t\u0131, ancak hisse o zamandan beri diren\u00e7 g\u00f6sterdi.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3>\n<p>CYTK hisseleri bir h\u0131z treni gibi hareket etti, y\u0131lba\u015f\u0131ndan bu yana <strong>%19,56<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131 ancak son zamanlarda istikrar g\u00f6steriyor:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 47,66 $ (tahmini YTD ba\u015flang\u0131\u00e7 noktas\u0131)<\/li>\n<li><strong>Nisan 2025<\/strong>: 42,90 $ (FDA gecikme endi\u015fesi \u00f6ncesi)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 37,35 $ (gecikme sonras\u0131 \u00e7\u00f6k\u00fc\u015f)<\/li>\n<li><strong>Haziran 2025<\/strong>: 36,18 $ (konsolidasyon d\u00f6nemi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 37,32-38,54 $ aral\u0131\u011f\u0131 (toparlanma denemesi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 38,34 $ (mevcut istikrar)<\/li>\n<\/ul>\n<p><strong>Neden bu volatilite?<\/strong> Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlara ba\u011fl\u0131 olarak y\u00fckselir ve d\u00fc\u015fer. CYTK&#8217;nin t\u00fcm gelece\u011fi aficamten&#8217;in Aral\u0131k FDA karar\u0131na ba\u011fl\u0131d\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli (2025)<\/h3>\n<p><strong>Aral\u0131k 2025 Hedefi<\/strong>: FDA aficamten&#8217;i onaylarsa 75-85 $ (+%95-120 y\u00fckseli\u015f)<br \/> <strong>En K\u00f6t\u00fc Senaryo<\/strong>: Reddedilirse 20-25 $ (-%35-48 d\u00fc\u015f\u00fc\u015f)<\/p>\n<p>Aral\u0131k karar\u0131n\u0131n ikili do\u011fas\u0131 a\u015f\u0131r\u0131 senaryolar yarat\u0131yor. \u00c7o\u011fu analist <strong>AL<\/strong> notu veriyor ve 27 analist takip ediyor: 4 tut, 17 al, 6 g\u00fc\u00e7l\u00fc al olarak <a href=\"https:\/\/valueinvesting.io\/CYTK\/estimates\">Value Investing verilerine<\/a> g\u00f6re.<\/p>\n<h3>Orta Vadeli (2026)<\/h3>\n<p><strong>Onay Senaryosu<\/strong>: 100-120 $ (ticari lansman ba\u015far\u0131s\u0131)<br \/> <strong>Reddetme Senaryosu<\/strong>: 15-20 $ (yeniden yap\u0131land\u0131rma veya sat\u0131n alma hedefi)<\/p>\n<h3>Uzun Vadeli (2028-2030)<\/h3>\n<p><strong>Bo\u011fa Senaryosu<\/strong>: 150-200+ $ (ba\u015far\u0131l\u0131 ila\u00e7 lansmanlar\u0131, \u00fcr\u00fcn hatt\u0131 geni\u015flemesi)<br \/> <strong>Temel Senaryo<\/strong>: 80-120 $ (istikrarl\u0131 ticari performans)<br \/> <strong>Ay\u0131 Senaryosu<\/strong>: &lt;10 $ (klinik ba\u015far\u0131s\u0131zl\u0131klar, finansal s\u0131k\u0131nt\u0131)<\/p>\n<p><strong>Karar<\/strong>: Y\u00dcKSEK R\u0130SK ama potansiyel Y\u00dcKSEK \u00d6D\u00dcL \u2192 <strong>R\u0130SK TOLERANSI OLAN YATIRIMCILAR \u0130\u00c7\u0130N SPEK\u00dcLAT\u0130F ALIM<\/strong><\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>\ud83d\udea8 Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>FDA Reddetme Riski<\/strong>: Aral\u0131k karar\u0131 \u015firketi tamamen raydan \u00e7\u0131karabilir<\/li>\n<li><strong>SEC Soru\u015fturmas\u0131<\/strong>: Klinik veri i\u015fleme uygulamalar\u0131na y\u00f6nelik devam eden inceleme (<a href=\"https:\/\/www.ainvest.com\/news\/cytokinetics-scrutiny-sec-investigation-investor-implications-2505\/\">AInvest raporu<\/a>)<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: 1,1 milyar $ rezerv olmas\u0131na ra\u011fmen ila\u00e7 geli\u015ftirme h\u0131zla nakit t\u00fcketiyor<\/li>\n<li><strong>Rekabet<\/strong>: Benzer kalp tedavileri geli\u015ftiren di\u011fer \u015firketler<\/li>\n<li><strong>\u0130kili Olay Riski<\/strong>: Tek ilaca ba\u011f\u0131ml\u0131l\u0131k hisseyi a\u015f\u0131r\u0131 volatil yap\u0131yor<\/li>\n<\/ul>\n<h3>\ud83d\udc9a 2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>1,1 Milyar Dolar Nakit Rezerv<\/strong>: Ticarile\u015ftirme i\u00e7in b\u00fcy\u00fck nakit rezervi (<a href=\"https:\/\/ir.cytokinetics.com\/press-releases\/press-release-details\/2025\/Cytokinetics-Announces-New-PDUFA-Date-for-Aficamten-in-Obstructive-Hypertrophic-Cardiomyopathy-05-01-2025\/default.aspx\">\u015eirket raporu<\/a>)<\/li>\n<li><strong>Potansiyel Blockbuster<\/strong>: Aficamten zirve sat\u0131\u015flarda 1,5-2 milyar $ gelir yaratabilir<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc Faz 3 Verileri<\/strong>: Etkinli\u011fi destekleyen sa\u011flam klinik sonu\u00e7lar<\/li>\n<li><strong>K\u00fcresel Ortakl\u0131klar<\/strong>: Asya pazarlar\u0131 i\u00e7in Ji Xing Pharmaceuticals ile anla\u015fmalar<\/li>\n<li><strong>Sekt\u00f6r Trendi<\/strong>: Kardiyovask\u00fcler ila\u00e7lar b\u00fcy\u00fck kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 temsil ediyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>A\u00e7\u0131kl\u0131k Bekleyin<\/strong>: Aral\u0131k FDA karar\u0131 y\u00f6n verecek\u2014o zamana kadar b\u00fcy\u00fck pozisyonlardan ka\u00e7\u0131n\u0131n<\/li>\n<li><strong>K\u00fc\u00e7\u00fck Pozisyon Boyutlar\u0131<\/strong>: Al\u0131m yap\u0131yorsan\u0131z, CYTK&#8217;y\u0131 toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden az tutun<\/li>\n<li><strong>Zarar Durdur Seviyeleri Belirleyin<\/strong>: FDA aficamten&#8217;i reddederse felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 koruma sa\u011flay\u0131n<\/li>\n<li><strong>SEC Soru\u015fturmas\u0131n\u0131 Takip Edin<\/strong>: \u00c7\u00f6z\u00fcm \u00f6nemli bir y\u00fck\u00fc kald\u0131rabilir<\/li>\n<\/ol>\n<p><strong>Mizahi Bak\u0131\u015f<\/strong>: &#8220;CYTK ticareti, anestezisiz kalp ameliyat\u0131 yapmak gibidir\u2014ba\u015far\u0131l\u0131 olursan\u0131z heyecan verici, olmazsa ac\u0131 verici. Belki defibrilat\u00f6r\u00fc yan\u0131n\u0131zda tutun!&#8221;<\/p>\n<h2>\u2705 Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Y\u00fcksek risk nedeniyle k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;CYTK&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014bir\u00e7ok platform $0 komisyon sunar<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<td>FDA haberleri ve \u00f6nemli fiyat hareketlerini takip edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Dolar maliyeti ortalamas\u0131 yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 zamana yay<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Tezinizi belgeleyin<\/td>\n<td>Duygusal kararlardan ka\u00e7\u0131nmak i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option CYTK Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>CYTK&#8217;nin potansiyeline ilgi duyan ancak risklerden \u00e7ekinenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri minimal riskle test edin<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> \u2014 Herhangi bir kimlik belgesini y\u00fckleyin ve h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdan veya banka kartlar\u0131yla karlar\u0131n\u0131za eri\u015fim esnekli\u011fi<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, CYTK gibi y\u00fcksek volatiliteye sahip hisselerde \u00f6nemli sermaye riske atmadan denemeler yapmak i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Cytokinetics: Kalp \u0130lac\u0131 Yenilik\u00e7isi<\/h2>\n<p>Cytokinetics, 28 y\u0131ll\u0131k tarihinde kritik bir d\u00f6n\u00fcm noktas\u0131nda. 1997&#8217;de kurulan ve merkezi G\u00fcney San Francisco&#8217;da bulunan \u015firket, kalp tedavilerine odaklanan kas biyolojisi ara\u015ft\u0131rmalar\u0131nda \u00f6nc\u00fc oldu. 498 \u00e7al\u0131\u015fan\u0131 ve 4,59 milyar $ piyasa de\u011feri ile CYTK, klasik bir biyoteknoloji hikayesini temsil ediyor: y\u0131llarca s\u00fcren ara\u015ft\u0131rmalar, kritik bir d\u00fczenleyici karar\u0131n e\u015fi\u011finde.<\/p>\n<p>\u015eirketin \u00f6nc\u00fc ilac\u0131 aficamten, kalp kas\u0131 fonksiyonunu etkileyen obstr\u00fcktif hipertrofik kardiyomiyopatiyi hedefliyor. Onaylan\u0131rsa, Cytokinetics&#8217;in ilk ticari \u00fcr\u00fcn\u00fc olacak ve \u015firketi ara\u015ft\u0131rma odakl\u0131dan gelir getiren bir yap\u0131ya d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Cytokinetics CEO&#8217;su Robert Blum, 2013&#8217;ten beri \u015firketi bir\u00e7ok klinik deneme a\u015famas\u0131ndan ge\u00e7iriyor ve hala ilk FDA onay\u0131n\u0131 bekleyen en uzun s\u00fcre g\u00f6rev yapan biyoteknoloji CEO&#8217;lar\u0131ndan biri\u2014bu hem sabr\u0131n hem de ila\u00e7 geli\u015ftirme zorluklar\u0131n\u0131n bir g\u00f6stergesi.<\/p>\n"},"faq":[{"question":"Cytokinetics (CYTK) hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CYTK\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak sipari\u015f verin ve fiyat uyar\u0131lar\u0131 ayarlay\u0131n."},{"question":"CYTK hisselerinin riskleri nelerdir?","answer":"FDA reddi, SEC soru\u015fturmas\u0131, y\u00fcksek nakit t\u00fcketimi, rekabet ve tek ilaca ba\u011f\u0131ml\u0131l\u0131k gibi riskler bulunmaktad\u0131r."},{"question":"Aficamten ilac\u0131n\u0131n onaylanmas\u0131 CYTK hisselerini nas\u0131l etkiler?","answer":"Onaylanmas\u0131 durumunda hisse fiyat\u0131 %95-120 aras\u0131nda artabilir, reddedilirse %35-48 aras\u0131nda d\u00fc\u015febilir."},{"question":"Yeni ba\u015flayanlar CYTK hissesi al\u0131rken nelere dikkat etmeli?","answer":"Aral\u0131k FDA karar\u0131n\u0131 beklemek, k\u00fc\u00e7\u00fck pozisyonlar almak, zarar durdur seviyeleri belirlemek ve SEC soru\u015fturmas\u0131n\u0131 takip etmek \u00f6nemlidir."},{"question":"Pocket Option CYTK yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile y\u00fcksek volatiliteye sahip hisselerde deneme yapmak i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Cytokinetics (CYTK) hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CYTK\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak sipari\u015f verin ve fiyat uyar\u0131lar\u0131 ayarlay\u0131n."},{"question":"CYTK hisselerinin riskleri nelerdir?","answer":"FDA reddi, SEC soru\u015fturmas\u0131, y\u00fcksek nakit t\u00fcketimi, rekabet ve tek ilaca ba\u011f\u0131ml\u0131l\u0131k gibi riskler bulunmaktad\u0131r."},{"question":"Aficamten ilac\u0131n\u0131n onaylanmas\u0131 CYTK hisselerini nas\u0131l etkiler?","answer":"Onaylanmas\u0131 durumunda hisse fiyat\u0131 %95-120 aras\u0131nda artabilir, reddedilirse %35-48 aras\u0131nda d\u00fc\u015febilir."},{"question":"Yeni ba\u015flayanlar CYTK hissesi al\u0131rken nelere dikkat etmeli?","answer":"Aral\u0131k FDA karar\u0131n\u0131 beklemek, k\u00fc\u00e7\u00fck pozisyonlar almak, zarar durdur seviyeleri belirlemek ve SEC soru\u015fturmas\u0131n\u0131 takip etmek \u00f6nemlidir."},{"question":"Pocket Option CYTK yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile y\u00fcksek volatiliteye sahip hisselerde deneme yapmak i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T17:28:52+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-24T17:28:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\",\"name\":\"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-24T17:28:52+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/","og_locale":"tr_TR","og_type":"article","og_title":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T17:28:52+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-24T17:28:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/","name":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-24T17:28:52+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Cytokinetics, Incorporated (CYTK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Cytokinetics, Incorporated (CYTK) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":345223,"slug":"how-to-buy-cytokinetics-incorporated","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cytokinetics, Incorporated (CYTK) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cytokinetics, Incorporated (CYTK)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/"},"pt_AA":{"locale":"pt_AA","id":345225,"slug":"how-to-buy-cytokinetics-incorporated","post_title":"Como comprar a\u00e7\u00f5es da Cytokinetics, Incorporated (CYTK) - Investimento em a\u00e7\u00f5es da Cytokinetics, Incorporated (CYTK)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-cytokinetics-incorporated\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/345226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=345226"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/345226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=345226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=345226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=345226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}